Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Characteristics of responders and non-responders to risperidone monotherapy or placebo in co-occurring bipolar disorder and anxiety disorder.

Seo JS, Jamieson K, Cosgrove V, Gwizdowski IS, Yang H, Sheehan DV, McElroy SL, Suppes T.

Eur Psychiatry. 2013 Mar;28(3):190-6. doi: 10.1016/j.eurpsy.2011.08.001. Epub 2011 Nov 29.

PMID:
22130178
2.

Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.

Sheehan DV, McElroy SL, Harnett-Sheehan K, Keck PE Jr, Janavs J, Rogers J, Gonzalez R, Shivakumar G, Suppes T.

J Affect Disord. 2009 Jun;115(3):376-85. doi: 10.1016/j.jad.2008.10.005. Epub 2008 Nov 29.

PMID:
19042026
3.

A randomized, double-blind, placebo-controlled study of ziprasidone monotherapy in bipolar disorder with co-occurring lifetime panic or generalized anxiety disorder.

Suppes T, McElroy SL, Sheehan DV, Hidalgo RB, Cosgrove VE, Gwizdowski IS, Feldman NS.

J Clin Psychiatry. 2014 Jan;75(1):77-84. doi: 10.4088/JCP.12m08297.

PMID:
24345758
4.

Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study.

Hirschfeld RM, Weisler RH, Raines SR, Macfadden W; BOLDER Study Group.

J Clin Psychiatry. 2006 Mar;67(3):355-62.

PMID:
16649820
5.

Randomized, placebo-controlled trial of quetiapine XR and divalproex ER monotherapies in the treatment of the anxious bipolar patient.

Sheehan DV, Harnett-Sheehan K, Hidalgo RB, Janavs J, McElroy SL, Amado D, Suppes T.

J Affect Disord. 2013 Feb 15;145(1):83-94. doi: 10.1016/j.jad.2012.07.016. Epub 2012 Aug 21.

PMID:
22920718
6.

Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review.

Gao K, Muzina D, Gajwani P, Calabrese JR.

J Clin Psychiatry. 2006 Sep;67(9):1327-40. Review.

PMID:
17017818
7.

Adjunctive risperidone in generalized anxiety disorder: a double-blind, placebo-controlled study.

Brawman-Mintzer O, Knapp RG, Nietert PJ.

J Clin Psychiatry. 2005 Oct;66(10):1321-5.

PMID:
16259547
8.

An open-label trial of risperidone augmentation for refractory anxiety disorders.

Simon NM, Hoge EA, Fischmann D, Worthington JJ, Christian KM, Kinrys G, Pollack MH.

J Clin Psychiatry. 2006 Mar;67(3):381-5.

PMID:
16649823
9.

An open-label extension trial of risperidone monotherapy in the treatment of bipolar I disorder.

Hirschfeld RM, Eerdekens M, Kalali AH, Canuso CM, Khan AA, Karcher K, Palumbo JM.

Int Clin Psychopharmacol. 2006 Jan;21(1):11-20.

PMID:
16317312
10.

Adjunctive risperidone in the treatment of generalized anxiety disorder: a double-blind, prospective, placebo-controlled, randomized trial.

Pandina GJ, Canuso CM, Turkoz I, Kujawa M, Mahmoud RA.

Psychopharmacol Bull. 2007;40(3):41-57.

PMID:
18007568
11.

Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study.

Haas M, Delbello MP, Pandina G, Kushner S, Van Hove I, Augustyns I, Quiroz J, Kusumakar V.

Bipolar Disord. 2009 Nov;11(7):687-700. doi: 10.1111/j.1399-5618.2009.00750.x.

PMID:
19839994
12.

Pharmacologic treatment considerations in co-occurring bipolar and anxiety disorders.

Keck PE Jr, Strawn JR, McElroy SL.

J Clin Psychiatry. 2006;67 Suppl 1:8-15. Review.

13.

A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently.

Macfadden W, Alphs L, Haskins JT, Turner N, Turkoz I, Bossie C, Kujawa M, Mahmoud R.

Bipolar Disord. 2009 Dec;11(8):827-39. doi: 10.1111/j.1399-5618.2009.00761.x.

PMID:
19922552
14.
15.

Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).

Thase ME, Macfadden W, Weisler RH, Chang W, Paulsson B, Khan A, Calabrese JR; BOLDER II Study Group.

J Clin Psychopharmacol. 2006 Dec;26(6):600-9. Erratum in: J Clin Psychopharmacol. 2007 Feb;27(1):51.

PMID:
17110817
16.

Risperidone in the treatment of acute mania: double-blind, placebo-controlled study.

Khanna S, Vieta E, Lyons B, Grossman F, Eerdekens M, Kramer M.

Br J Psychiatry. 2005 Sep;187:229-34.

17.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
18.

A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.

DelBello MP, Chang K, Welge JA, Adler CM, Rana M, Howe M, Bryan H, Vogel D, Sampang S, Delgado SV, Sorter M, Strakowski SM.

Bipolar Disord. 2009 Aug;11(5):483-93. doi: 10.1111/j.1399-5618.2009.00728.x.

PMID:
19624387
19.

Risperidone in combination with mood stabilizers: a 10-week continuation phase study in bipolar I disorder.

Bowden CL, Myers JE, Grossman F, Xie Y.

J Clin Psychiatry. 2004 May;65(5):707-14.

PMID:
15163260
20.

Supplemental Content

Support Center